☰
Companies
▾
Companies
Calendar
Valuation
Screener
▾
Screener
STOXX 600
Sectors
Magic Formula
Bubble Plot
Treemap
Chart Builder
Analysis
▾
Margins
Dividends
Buybacks
Insider Buying
CEO Changes
M&A Tracker
IPO Tracker
Short Selling
Markets
▾
Countries
US vs EU P/E
Fear & Greed
AI Models
AI Capex
Credit & Rates
▾
EU Yield Curve
US Yield Curve
US Federal Debt
Leverage
Repo Market
Mortgage Delinquency
Private Credit
Health
▾
Drugs
Drug Sales
Drug Approvals
Diabetes
Immunology
Portfolio
▾
Portfolio
Berkshire
Buffett
Fund X-Ray
More
▾
Denmark
Danish Tax
Tesla
SpaceX
EU XBRL Tables
Contact
Obesity
Blog
Trulicity
1 post
Diabetes and the third quarter of 2019
2 November 2019
·
Diabetes
Eli Lilly
Europe
Novo Nordisk and Eli Lilly have both reported their Q3 results. Below are some of the headlines related to their diabetes business.